1. Home
  2. BVS vs BGY Comparison

BVS vs BGY Comparison

Compare BVS & BGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • BGY
  • Stock Information
  • Founded
  • BVS 2011
  • BGY 2007
  • Country
  • BVS United States
  • BGY United States
  • Employees
  • BVS N/A
  • BGY N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BGY Trusts Except Educational Religious and Charitable
  • Sector
  • BVS Health Care
  • BGY Finance
  • Exchange
  • BVS Nasdaq
  • BGY Nasdaq
  • Market Cap
  • BVS 496.7M
  • BGY 487.0M
  • IPO Year
  • BVS 2021
  • BGY N/A
  • Fundamental
  • Price
  • BVS $6.48
  • BGY $5.81
  • Analyst Decision
  • BVS Strong Buy
  • BGY
  • Analyst Count
  • BVS 4
  • BGY 0
  • Target Price
  • BVS $15.00
  • BGY N/A
  • AVG Volume (30 Days)
  • BVS 515.1K
  • BGY 208.4K
  • Earning Date
  • BVS 05-06-2025
  • BGY 01-01-0001
  • Dividend Yield
  • BVS N/A
  • BGY 7.41%
  • EPS Growth
  • BVS N/A
  • BGY N/A
  • EPS
  • BVS N/A
  • BGY N/A
  • Revenue
  • BVS $567,699,000.00
  • BGY N/A
  • Revenue This Year
  • BVS N/A
  • BGY N/A
  • Revenue Next Year
  • BVS $6.11
  • BGY N/A
  • P/E Ratio
  • BVS N/A
  • BGY N/A
  • Revenue Growth
  • BVS 8.60
  • BGY N/A
  • 52 Week Low
  • BVS $5.28
  • BGY $4.68
  • 52 Week High
  • BVS $14.38
  • BGY $5.66
  • Technical
  • Relative Strength Index (RSI)
  • BVS 40.43
  • BGY 58.34
  • Support Level
  • BVS $6.35
  • BGY $5.75
  • Resistance Level
  • BVS $6.72
  • BGY $5.95
  • Average True Range (ATR)
  • BVS 0.28
  • BGY 0.08
  • MACD
  • BVS 0.06
  • BGY -0.00
  • Stochastic Oscillator
  • BVS 34.46
  • BGY 50.00

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About BGY Blackrock Enhanced International Dividend Trust

Blackrock Enhanced International Dividend Trust has an investment objective to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its objectives by investing in equity securities of companies engaged in the energy and natural resources business and equity derivatives with exposure to the energy and natural resources industry.

Share on Social Networks: